NCT00214851View on ClinicalTrials.gov

The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Familial Cold Urticaria
Interventions
DRUG

Kineret (anakinra)

Kineret (anakinra 100 mg. s/c daily x 4 weeks

Trial Locations (1)

B3H 1V7

Queen Elizabeth Health Sciences Centre, Halifax

All Listed Sponsors
collaborator

Atlantic Provinces Dermatology Association

UNKNOWN

lead

Nova Scotia Health Authority

OTHER

NCT00214851 - The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria | Biotech Hunter | Biotech Hunter